🕵️ Healthcare Realty Trust Inc ($HR)
SEC insider & ownership activity, last 12 months · CIK 1360604 · every row links its SEC filing
Over the last 12 months insiders sold $926K against $181K of open-market buying. Amanda L. Callaway sold $525K in discretionary trades (Jun). No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
2 buyers, $181K (2 lots) · 2 sellers, $926K (2 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Amanda L. Callaway | 0 | – | 1 | $525K | Jun 23, 2026 |
| Robert E. Hull | 0 | – | 1 | $401K | Sep 8, 2026 |
| Thomas N. Bohjalian | 1 | $181K | 0 | – | Mar 6, 2026 |
| Gabbay Daniel | 1 | $187 | 0 | – | Mar 4, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Cohen & Steers, Inc. | 16.1% | 13G | Nov 14, 2025 | filing ↗ | |
| Cohen & Steers Capital Management, Inc. | 15.9% | 13G | Nov 14, 2025 | filing ↗ | |
| Vanguard Portfolio Management | 8.2% | 13G | Apr 29, 2026 | filing ↗ | |
| Vanguard Capital Management | 5.3% | 13G | Apr 30, 2026 | filing ↗ | |
| State Street Corporation | 5.0% | 13G | Feb 9, 2026 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Robert E. Hull | $402K | Sep 8, 2026 | filing ↗ |
| Amanda L. Callaway | $519K | Jun 23, 2026 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Other events (8.01) | Jul 31, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 31, 2026 | filing ↗ |
| Earnings (2.02) | Jul 30, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jul 30, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 30, 2026 | filing ↗ |
| Shareholder vote (5.07) | May 20, 2026 | filing ↗ |
| Material agreement (1.01) | May 19, 2026 | filing ↗ |
| New financial obligation (2.03) | May 19, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 19, 2026 | filing ↗ |
| Material agreement (1.01) | May 7, 2026 | filing ↗ |
| New financial obligation (2.03) | May 7, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | May 7, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 7, 2026 | filing ↗ |
| Other events (8.01) | May 5, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 5, 2026 | filing ↗ |
| Earnings (2.02) | Apr 30, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Apr 30, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 30, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Feb 27, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 27, 2026 | filing ↗ |
| Auditor change (4.01) | Feb 19, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 19, 2026 | filing ↗ |
| Earnings (2.02) | Feb 12, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Feb 12, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 12, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jan 5, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jan 5, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 5, 2026 | filing ↗ |
| Material agreement (1.01) | Dec 17, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 17, 2025 | filing ↗ |